Source: Υπουργείο Υγείας (CY) Revision Year: 2016 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Storilat 200 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round, flat, scored tablets with Remedica’s logo on one side. The tablet can be divided into equal doses. |
Each tablet contains 200 mg carbamazepine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carbamazepine |
Carbamazepine is a derivative of dibenzazepine. It belongs to the pharmaceutical class of antiepileptic, neurotropic and psychotropic drugs. Carbamazepine helps control the transmission of messages from the brain to the muscles. |
| List of Excipients |
|---|
|
Core |
PVC/Aluminium blisters. Pack sizes of 50 and 100 tablets.
PP containers with PE closure. Pack sizes of 100, 500 and 1000 tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
8549
Date of first authorization: 20 November 1982
Date of latest renewal: 25 August 2008
| Drug | Countries | |
|---|---|---|
| STORILAT | Cyprus, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
